Jaime R Merchan

Associate Professor

  • 5869 Citations
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jaime R Merchan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Measles virus Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Deoxyglucose Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences
15-hydroxyprostaglandin dehydrogenase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2017

Oncolytic Viruses
Neoplasms
Viruses
Measles virus
Oncogenic Viruses
Kidney Neoplasms
Vascular Endothelial Growth Factor A
Renal Cell Carcinoma
Biomarkers
Therapeutics

Research Output 1998 2019

  • 5869 Citations
  • 45 Article
  • 1 Chapter
7 Citations (Scopus)

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial

Wilky, B. A., Trucco, M. M., Subhawong, T., Florou, V., Park, W., Kwon, D., Wieder, E., Kolonias, D., Rosenberg, A., Kerr, D., Sfakianaki, E., Foley, M., Merchan, J. R., Komanduri, K. V. & Trent, J. C., Jun 1 2019, In : The Lancet Oncology. 20, 6, p. 837-848 12 p.

Research output: Contribution to journalArticle

Alveolar Soft Part Sarcoma
Sarcoma
Disease-Free Survival
Therapeutics
pembrolizumab
5 Citations (Scopus)

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Mir, O., Azaro, A., Merchan, J. R., Chugh, R., Trent, J., Rodon, J., Ohnmacht, U., Diener, J. T., Smith, C., Yuen, E., Oakley, G. J., Le Cesne, A., Soria, J. C., Benhadji, K. A. & Massard, C., Nov 1 2018, In : European Journal of Cancer. 103, p. 88-97 10 p.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Sarcoma
Leiomyosarcoma
Safety
Disease-Free Survival
3 Citations (Scopus)

The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma

Palacio, S., Hosein, P., Reis, I., Akunyili, I. I., Ernani, V., Pollack, T., Macintyre, J., Restrepo, M. H., Merchan, J. R. & Lima, C. M. R., Feb 1 2018, In : Journal of Gastrointestinal Oncology. 9, 1, p. 135-139 5 p.

Research output: Contribution to journalArticle

gemcitabine
Adenocarcinoma
Pancreatic Neoplasms
Disease-Free Survival
Survival
3 Citations (Scopus)

Molecular effects of stromal-selective targeting by uPAR-retargeted oncolytic virus in breast cancer

Jing, Y., Chavez, V., Ban, Y., Acquavella, N., El-Ashry, D., Pronin, A., Chen, X. & Merchan, J. R., Oct 1 2017, In : Molecular Cancer Research. 15, 10, p. 1410-1420 11 p.

Research output: Contribution to journalArticle

Oncolytic Viruses
Measles virus
Breast Neoplasms
Neoplasms
Viruses
30 Citations (Scopus)

Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma

Narayanan, G., Hosein, P., Beulaygue, I. C., Froud, T., Scheffer, H. J., Venkat, S., Echenique, A., Hevert, E. C., Livingstone, A., Rocha-Lima, C. M., Merchan, J. R., Levi, J., Yrizarry, J. & Lencioni, R., Mar 1 2017, In : Journal of Vascular and Interventional Radiology. 28, 3, p. 342-348 7 p.

Research output: Contribution to journalArticle

Electroporation
Adenocarcinoma
Survival
Safety
Therapeutics